Use App
Trending
News
Earnings
Newsletters
Advertise
All
DIA
0.26%
SPY
0.39%
QQQ
0.85%
Trending
ABAT
70.39%
LAES
2.71%
MVST
31.53%
CRM
5.15%
TSM
4.17%
LULU
0.51%
BZAI
41.77%
QBTS
4.13%
OMER
149.73%
HIMS
12.10%
ABAT
70.39%
LAES
2.71%
MVST
31.53%
CRM
5.15%
TSM
4.17%
LULU
0.51%
BZAI
41.77%
QBTS
4.13%
OMER
149.73%
HIMS
12.10%
home
Symbol
MDNAF
MDNAF
Medicenna Therapeutics Corp
1,014
Loading...
Loading...
Feed
News
Sentiment
Earnings
Fundamentals
Info
News
all
press releases
Medicenna Therapeutics (MDNAF) Upgraded to Buy: Here's What You Should Know
Medicenna Therapeutics (MDNAF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
·
21d ago
Latest MDNAF News
View
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile